Centene Corporation $CNC Shares Bought by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC lifted its holdings in shares of Centene Corporation (NYSE:CNCFree Report) by 54.3% during the 3rd quarter, Holdings Channel.com reports. The firm owned 98,286 shares of the company’s stock after acquiring an additional 34,607 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Centene were worth $3,507,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in CNC. WPG Advisers LLC grew its holdings in Centene by 44.5% in the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after buying an additional 282 shares during the period. Versant Capital Management Inc grew its holdings in Centene by 11.6% in the third quarter. Versant Capital Management Inc now owns 3,421 shares of the company’s stock valued at $122,000 after purchasing an additional 355 shares during the period. Snowden Capital Advisors LLC increased its position in Centene by 8.0% during the second quarter. Snowden Capital Advisors LLC now owns 5,073 shares of the company’s stock worth $275,000 after purchasing an additional 374 shares during the last quarter. Financial Network Wealth Advisors LLC raised its stake in Centene by 54.9% during the third quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock worth $39,000 after purchasing an additional 390 shares during the period. Finally, Geneos Wealth Management Inc. boosted its holdings in shares of Centene by 29.8% in the 2nd quarter. Geneos Wealth Management Inc. now owns 1,897 shares of the company’s stock valued at $103,000 after purchasing an additional 435 shares during the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Stock Performance

Shares of NYSE:CNC opened at $41.89 on Thursday. The business’s 50-day simple moving average is $41.55 and its 200 day simple moving average is $35.33. The company has a market cap of $20.59 billion, a P/E ratio of -3.87, a PEG ratio of 0.95 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.08 and a current ratio of 1.08. Centene Corporation has a one year low of $25.08 and a one year high of $66.81.

Centene (NYSE:CNCGet Free Report) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.71. Centene had a negative net margin of 2.85% and a positive return on equity of 7.82%. The company had revenue of $49.69 billion during the quarter, compared to the consensus estimate of $47.50 billion. During the same quarter last year, the company earned $1.62 earnings per share. Centene’s revenue for the quarter was up 18.2% on a year-over-year basis. On average, sell-side analysts forecast that Centene Corporation will post 6.86 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on CNC. TD Cowen restated a “hold” rating on shares of Centene in a report on Friday, October 31st. Mizuho set a $47.00 price target on Centene in a research note on Friday, January 9th. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $38.00 price objective (up from $33.00) on shares of Centene in a research note on Thursday, October 30th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Centene from $24.00 to $32.00 in a research report on Friday, October 31st. Finally, Jefferies Financial Group lifted their price target on shares of Centene from $25.00 to $32.00 in a research report on Monday, November 3rd. Three research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $40.81.

View Our Latest Stock Analysis on CNC

Centene Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Featured Articles

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.